-
Symbol
-
PTGX on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.00001 par value
-
Latest Disclosed Shares Owned
-
6,248,013 shares
-
Security Ownership %
-
10%
Dapice Joshua J. ownership in Protagonist Therapeutics, Inc Common Stock, $0.00001 par value (PTGX)
06 Feb 2026 - Dapice Joshua J. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,248,013 shares of Protagonist Therapeutics, Inc Common Stock, $0.00001 par value (PTGX).
This represents 10% ownership of the company.
In their previous filing dated 10 Feb 2025, Farallon Capital Partners, L.P. had reported owning 5,956,488 shares, indicating an increase of +4.9%.
.